This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OKLearn moreDownload the investor presentation by entering your information below
Subscribe to our newsletter to stay up to date on what Supreme Cannabis and its brands are up to.
You can withdraw your consent at any time. You can reach us at info@supreme.ca. Our address is 178R Ossington Avenue, Toronto, ON M6J 2Z7. “We” in the consent above refers to The Supreme Cannabis Company, Inc. Supreme is seeking this consent on its own behalf, but will send messages about itself and its affiliates.
Supreme Pharmaceuticals Announces Continuance to CBCA and Adoption of By Law
/in 2015, Press Release /by adminDECEMBER 22, 2015 December 22, 2015, Toronto, ON–Supreme Pharmaceuticals Inc. (the “Company“) (SPRWF – OTC) (“SL” – CSE) is pleased to announce that the Company has continued (the “Continuance“) out of the jurisdiction of the Business Corporations Act (British Columbia) and into the jurisdiction of the Canada Business Corporations Act (the “CBCA“) and has adopted […]
Supreme Completes Pre-License Inspection
/in 2015, Press Release /by adminDECEMBER 10, 2015 December 10, 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (SPRWF – OTC) (“SL” – CSE) is pleased to announce on December 9, 2015, Health Canada conducted the Pre-License Inspection of Supreme’s hybrid greenhouse facility in Kincardine, Ontario. About Supreme Supreme is a Canadian publically traded company committed to […]
Supreme Announces Pre-License Inspection Date
/in 2015, Press Release /by adminDECEMBER 03, 2015 December 3, 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (SPRWF – OTC) (“SL” – CSE) is pleased to announce Health Canada has scheduled a pre-license inspection of Supreme’s hybrid greenhouse facility in Kincardine, Ontario on December 9, 2015. About Supreme Supreme is a Canadian publically traded company committed […]
Supreme Announces Warrant Exercise Incentive Program
/in 2015, Press Release /by adminDECEMBER 02, 2015 December 2, 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme”) (SPRWF – OTC) (“SL” – CSE) is pleased to announce a limited time incentive program (the “Incentive Program”) commencing December 7, 2015 to exercise 12,607,349 outstanding common share purchase warrants (the “April Warrants”) issued pursuant to the Company’s April 23, 2015 […]
Supreme Strengthens Management Team With Appointment of New Director
/in 2015, Press Release /by adminNOVEMBER 19, 2015 Thursday, November 19 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company” or “Supreme“) (OTC PINK:SPRWF)(CSE:SL) is pleased to announce the appointment of Navdeep Dhaliwal to the Company’s Board of Directors. Mr. Dhaliwal’s primary focus will be the development of Supreme’s go-to-market strategy in addition to corporate development and capital markets initiatives. […]
Supreme Reports Granting of Options
/in 2015, Press Release /by adminOCTOBER 14, 2015 October 14, 2014 – Supreme Pharmaceuticals Inc.(SPRWF – OTC) (“SL” – CSE) announced today that it has issued 4,100,000 stock options to directors, officers, employees and consultants.Each option entitles the holder to acquire one common share of the Company for a period of five years (3,900,000 options) or two years (200,000 options), at […]
Supreme Completes Private Placement for $684,449 Aggregate Subscription Proceeds
/in 2015, Press Release /by adminJULY 30, 2015 Thursday July 30th, 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company”) (SPRWF – OTC) (“SL” – CSE) is pleased to announce that it has closed a private placement financing (the “Financing”) for gross proceeds of $684,449.82. Upon closing the Financing, Supreme issued 4,026,469 units (“ Units”) at a price of $0.17 per Unit. Each […]
Supreme Completes Private Placement for Aggregate Total of $1.465M
/in 2015, Press Release /by adminAPRIL 23, 2015 Thursday, April 23, 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company“) (SPRWF – OTC) (“SL” – CSE) is pleased to announce that it has closed its previously disclosed non-brokered private placement (the “Financing“) of secured convertible debentures (the “Debentures“). At closing, the Company issued $1,465,580 [all currency references are in Canadian dollars] […]
Supreme Updates Debenture Offering Operations and Officer Changes
/in 2015, Press Release /by adminAPRIL 17, 2015 Friday April 17, 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company“) (SPRWF – OTC) (“SL” – CSE) announced today that it increased the size of its previously disclosed non-brokered private placement of secured convertible debentures (the “Financing“) in response to greater than anticipated investor demand and has closed the books on approximately $1.4 […]
Supreme Completes Operational Transition to Ontario
/in 2015, Press Release /by adminFEBRUARY 09, 2015 February 9th, 2015, Toronto, ON – Supreme Pharmaceuticals Inc. (the “Company”) (SPRWF – OTC) (“SL” – CSE) is pleased to announce it has completed its operational transition from British Columbia to Ontario in order to focus resources on the Kincardine facility. The transition allows the Company to reduce operating overhead and focus efforts […]
Supreme Completes Private Placement for $258,000
/in 2015, Press Release /by adminJANUARY 23, 2015 Friday January 23, 2015, Vancouver, BC – Supreme Pharmaceuticals Inc. (“Supreme” or the “Company“) (SL:CSE) is pleased to announce that it has closed a private placement financing (the “Financing“) on an oversubscribed basis for gross proceeds of $257,634.96. Upon closing the Financing, Supreme issued 780,712 units comprised of 780,712 common shares in the […]
A Letter from the President
/in 2015, Press Release /by adminJANUARY 05, 2015 Dear Supreme Investors: 2014 was a tremendous year for us. We successfully entered the medical marijuana space, acquired the 7-acre Kincardine greenhouse facility and its management team and we completed two successful financings. With your support, we have been one of the most successful MMPR applicant companies in the public markets, […]